Winthrop Pharmaceuticals UK Limited Trading as Zentiva
Molipaxin 100 mg capsules (PL 17780/0618)
||16 October 2017
Brief description of the problem
A precautionary recall is being carried out due to the potential that during manufacture of the batch, the metal detector may not have functioned and therefore that the presence of metal particles would not have been detected, if they were present. Although there is no evidence of metal particles within units from the batch, the batch is being recalled as a precautionary measure.
Advice for healthcare professionals & wholesalers
Please return affected stock from this batch to your supplier.
Medical information enquiries
For Medical information enquiries, please contact firstname.lastname@example.org.
For stock enquiries, please contact GB-CustomerServices@sanofi.com.
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to relevant clinics, hospitals, mental health trusts, general practitioners and community pharmacists for information.